These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28178069)

  • 21. Naringin treatment induces neuroprotective effects in a mouse model of Parkinson's disease in vivo, but not enough to restore the lesioned dopaminergic system.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Nutr Biochem; 2016 Feb; 28():140-6. PubMed ID: 26878791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment.
    Mendes-Oliveira J; Lopes Campos F; Videira RA; Baltazar G
    Brain Behav Immun; 2017 Aug; 64():296-307. PubMed ID: 28450223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Acetyl-7-hydroxy-6-methoxy-1-methyl-1,2,3,4,-tetrahydroisoquinoline exhibits anti-inflammatory properties and protects the nigral dopaminergic neurons.
    Son HJ; Han SH; Lee JA; Lee CS; Seo JW; Chi DY; Hwang O
    Eur J Pharmacol; 2016 Jan; 771():152-61. PubMed ID: 26687634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease.
    Yin LH; Shen H; Diaz-Ruiz O; Bäckman CM; Bae E; Yu SJ; Wang Y
    BMC Neurosci; 2012 Oct; 13():120. PubMed ID: 23040108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
    Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
    Chan WS; Durairajan SS; Lu JH; Wang Y; Xie LX; Kum WF; Koo I; Yung KK; Li M
    Neurochem Int; 2009 Nov; 55(6):414-22. PubMed ID: 19409437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats.
    Salama M; Helmy B; El-Gamal M; Reda A; Ellaithy A; Tantawy D; Mohamed M; El-Gamal A; Sheashaa H; Sobh M
    Environ Toxicol Pharmacol; 2013 Mar; 35(2):270-7. PubMed ID: 23357603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newborn dopaminergic neurons are associated with the migration and differentiation of SVZ-derived neural progenitors in a 6-hydroxydopamin-injected mouse model.
    Xie MQ; Chen ZC; Zhang P; Huang HJ; Wang TT; Ding YQ; Qi SS; Zhang C; Chen SX; Zhou P; Shao CC; Liao M; Sun CY
    Neuroscience; 2017 Jun; 352():64-78. PubMed ID: 28385636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice.
    Watson MB; Nobuta H; Abad C; Lee SK; Bala N; Zhu C; Richter F; Chesselet MF; Waschek JA
    Neuroscience; 2013 Jun; 240():277-86. PubMed ID: 23500093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcγR I and TLR4 pathways.
    Zhang J; Niu N; Wang M; McNutt MA; Zhang D; Zhang B; Lu S; Liu Y; Liu Z
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1911-20. PubMed ID: 23791745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
    Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration.
    Neal ML; Fleming SM; Budge KM; Boyle AM; Kim C; Alam G; Beier EE; Wu LJ; Richardson JR
    FASEB J; 2020 Jan; 34(1):1679-1694. PubMed ID: 31914683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 6-Hydroxydopamine as a tool to understand adaptive immune system-induced dopamine neurodegeneration in Parkinson's disease.
    Theodore S; Maragos W
    Immunopharmacol Immunotoxicol; 2015; 37(4):393-9. PubMed ID: 26211726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.
    Decressac M; Pain S; Chabeauti PY; Frangeul L; Thiriet N; Herzog H; Vergote J; Chalon S; Jaber M; Gaillard A
    Neurobiol Aging; 2012 Sep; 33(9):2125-37. PubMed ID: 21816512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGF18 protects against 6-hydroxydopamine-induced nigrostriatal damage in a rat model of Parkinson's disease.
    Guo X; Liu T; Zhao D; Wang X; Liu D; He Y; Shan C; Kong Y; Hu W; Tao B; Sun L; Zhao H; Li S; Liu J
    Neuroscience; 2017 Jul; 356():229-241. PubMed ID: 28504195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
    Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
    Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular Zn
    Tamano H; Nishio R; Morioka H; Takeda A
    Mol Neurobiol; 2019 Jan; 56(1):435-443. PubMed ID: 29705946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway.
    Lou H; Jing X; Wei X; Shi H; Ren D; Zhang X
    Neuropharmacology; 2014 Apr; 79():380-8. PubMed ID: 24333330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease.
    Ren B; Zhang YX; Zhou HX; Sun FW; Zhang ZF; Wei Z; Zhang CY; Si DW
    J Neurol Sci; 2015 Jan; 348(1-2):142-52. PubMed ID: 25491263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Silibinin Against Prothrombin Kringle-2-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System In Vivo.
    Leem E; Oh YS; Shin WH; Jin BK; Jeong JY; Shin M; Kim DW; Jang JH; Kim HJ; Ha CM; Jung UJ; Moon GJ; Kim SR
    J Med Food; 2019 Mar; 22(3):277-285. PubMed ID: 30632945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.